Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Christina Stallings

Washington University, Department: Microbiology/immun/virology

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Fimbrion

Disclosed Value
Listed Reason
Other : Licensing through awardee institution

The committees determined Dr. Stallings personal financial relationship with Fimbrion, related to the above referenced research, creates a financial conflict of interest due to the following reasons:

• Dr. Stallings’s personal financial relationship with Fimbrion is directly related to the research because the research is evaluating a technology she coinvented, which is being licensed to Fimbrion

• Dr. Stallings is entitled to future royalties from the sale and distribution of the licensed technology being evaluated in the research

• The primary focus of Fimbrion is to commercialize the IP being developed and evaluated in the above mentioned research

• The outcomes of the research could directly benefit Fimbrion

• Dr. Stallings’s role as described above could directly affect all aspects of the studies

While the committees determined financial conflicts of interest exist, they concluded sufficient mechanisms exist to ensure the objectivity and integrity of the research, based on the following reasons:

• The research is basic in nature and in its early stages.

• Dr. Stallings is uniquely qualified by virtue of her expertise and experience, and the research could not be conducted as effectively without her involvement

• Additionally, a plan has been developed to mitigate your financial conflict of interest

Listed Research Project
Targeting a New Essential Virulence Mechanism in Drug-Resistant Mycobacteria

The World Health Organization reported 8.7 million new cases of Tuberculosis (TB) in 2011, contributing to the 2 billion people infected with Mycobacterium tuberculosis worldwide and 1.4 million TB related deaths that year. This urgent health crisis is exacerbated by the alarming emergence of drug resistant strains. The experiments proposed will develop novel therapeutic strategies to combat both drug-sensitive and drug-resistant TB cases.

Filed on November 15, 2018.

Tell us what you know about Christina Stallings's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
Christina Stallings Washington University Conflict of Interest Fimbrion $10,000 - $19,999
Christina Stallings Washington University Conflict of Interest Quretech Bio Value cannot be readily determined
Christina Stallings Washington University Conflict of Interest Quretech Bio Value cannot be readily determined
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page